Schizophrenia: Core Interventions in the Treatment and Management of Schizophrenia in Primary and Secondary Care (Update) [Internet]

Sections

• Guideline Development Group members
• Acknowledgements
• 1. Preface
• 2. Schizophrenia
• 3. Methods used to update this guideline
• 4. Experience of care
• 5. Access and engagement
• 6. Pharmacological interventions in the treatment and management of schizophrenia
• 7. Economic model – cost effectiveness of pharmacological interventions for people with schizophrenia
• 8. Psychological therapy and psychosocial interventions in the treatment and management of schizophrenia
• 9. Service-level interventions in the treatment and management of schizophrenia
• 10. Clinical evidence summary tables
• 11. Summary of recommendations
• Appendix 1 Scope for the development of the clinical guideline
• Appendix 2 Declarations of interests by GDG members
• Appendix 3 Special advisors to the Guideline Development Group
• Appendix 4 Stakeholders and experts who submitted comments in response to the consultation draft of the guideline
• Appendix 5 Researchers contacted to request information about unpublished or soon-to-be published studies
• Appendix 6 Analytic framework and clinical questions
• Appendix 7 Clinical review protocol template
• Appendix 8 Search strategies for the identification of clinical studies
• Appendix 9 Quality checklists for clinical studies and reviews
• Appendix 10 Search strategies for the identification of health economics evidence
• Appendix 11 Quality checklist for economic studies
• Appendix 12 Data extraction form for economic studies
• Appendix 13 Winbugs codes used for Mixed Treatment Comparisons in the economic model of pharmacological treatments for relapse prevention
• Appendix 14 Evidence tables for economic studies
• Appendix 15 Study characteristics tables
• Appendix 16 Clinical evidence forest plots
• Appendix 17 Previous guideline methodology
• References